News
-
-
-
-
PRESS RELEASE
Presentation at European Society of Cardiology Demonstrates VIVO Accuracy in Complex VT Patients
Catheter Precision announces VIVO interim results for VT localization at ESC Symposium, showcasing non-invasive mapping system accuracy in relation to myocardial scar in heart disease patients -
-
PRESS RELEASE
Catheter Precision, Inc. (NYSE American:VTAK) Reports First Purchase Order for LockeT in a New US Territory
Catheter Precision, Inc. reveals first purchase order for LockeT suture retention device from a Chicago hospital within the Endeavor Health System, marking a significant milestone in US market expansion -
-
PRESS RELEASE
Catheter Precision, Inc. Announces Closing of $3.6 Million Underwritten Public Offering and Exercise of Overallotment Option
Catheter Precision, Inc. announces closing of public offering of common stock units and pre-funded warrant units. Ladenburg Thalmann & Co. Inc. acted as the sole book-running manager -
-
PRESS RELEASE
Catheter Precision, Inc. Announces Pricing of $3.1 Million Underwritten Public Offering
Catheter Precision, Inc. announces pricing of underwritten public offering of common stock units and pre-funded units, expecting $3.1 million gross proceeds. Details include warrants, offering conditions, book-running manager, and SEC registration